0 items USD 0.00Search
Your search for "delveinsight methicillin resistant staphylococcus aureus mrsa market insights epidemiology" gave back 1543374 results.
Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections (Infectious Disease) - Drugs in Development, 2021 Summary Global...
Catalog:
Global Markets Direct
December 2021
Price: USD 2,000.00
Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical...
Catalog:
Global Markets Direct
December 2019
Price: USD 2,000.00
MRSA drugs are antibiotics or antimicrobial agents specifically designed to treat infections caused by methicillin-resistant Staphylococcus aureus (...
Catalog:
MRRPB5
April 2024
Price: USD 2,900.00
Methicillin-resistant Staphylococcus aureus (MRSA) testing is utilized to detect MRSAs and no other microbes. It is prominently employed in hospitals...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections - Pipeline Review, H2 2019 Summary Global Markets Direct's...
Catalog:
Global Markets Direct
December 2019
Price: USD 2,000.00
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022...
Catalog:
Global Markets Direct
September 2022
Price: USD 2,500.00
Highlights The global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs market was valued at US$ 3306.9 million in 2022 and is anticipated to...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Methicillin-resistant Staphylococcus aureus (MRSA) testing is utilized to detect MRSAs and no other microbes. It is prominently employed in hospitals...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Pipeline Review, H1 2020 Summary Global Markets Direct's latest Pharmaceutical...
Catalog:
Global Markets Direct
May 2020
Price: USD 2,000.00
Highlights The global Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug market was valued at US$ million in 2022 and is...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
Highlights The global Methicillin Resistant Staphylococcus Aureus (MRSA) Drugs market was valued at US$ million in 2022 and is anticipated to reach...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Infections (Infectious Disease) - Drugs in Development, 2021 Summary...
Catalog:
Global Markets Direct
April 2021
Price: USD 2,000.00
Summary HeyReport estimates that the Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug market size will grow from xxx...
Catalog:
HYR
July 2021
Price: USD 2,000.00
Summary HeyReport estimates that the Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug market size will grow from xxx...
Catalog:
HYR
January 2021
Price: USD 2,000.00
The global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug market size is expected to reach $ million by 2029, rising at a...
Catalog:
GIR
March 2023
Price: USD 4,480.00
